Search Results for compound

Matched symptoms: … , excitement, and a phosphorus smell on the breath. Higher levels can cause weakness, bronchitis ... , pulmonary edema, shortness of breath, convulsions, and death. Some effects, such as pulmonary edema ... , convulsions, and liver injury, may appear or continue to be present days after an exposure. Ingestion of …
Matched treatment: … respiration, gastric lavage, and/or administration of activated charcoal may be necessary. (L982) …
Matched description: … stomach acid. Phosphine is a colorless, flammable, explosive, and toxic gas. (L980, L986) ... Indium phosphide is a phosphide of indium. It is a semiconductor used in high-power and high ... semiconductors silicon and gallium arsenide. It also has a direct bandgap, making it useful for …

Matched symptoms: … Bromine vapour causes irritation and direct damage to the mucous membranes. Symptoms include ... lacrimation, rhinorrhoea, eye irritation with mucous secretions from the oropharyngeal and upper airways ... , coughing, dyspnoea, choking, wheezing, epistaxis, and headache. The bromide ion is a central nervous …
Matched treatment: … cold running water for at least 15 minutes, followed by thorough washing with soap and water. If ... necessary, the person should shower and change contaminated clothing and shoes, and then must seek …
Matched description: … Calcium bromide is a chemical compound of calcium and bromine. It can be found in drilling fluids ... , neuroses medication, freezing mixtures, food preservatives, photography and fire retardants. Bromine ... is a halogen element with the symbol Br and atomic number 35. Diatomic bromine does not occur …
Matched synonyms: … Hydrobromic acid calcium salt …

Matched symptoms: … , headache and, in extreme cases, seizures, comas, and death. There are also associated gastrointestinal ... ulcers, runny nose, and breathing problems, such as asthma, cough, shortness of breath, or wheezing ... . Ingestion of hexavalent chromium causes irritation and ulcers in the stomach and small intestine, as …
Matched description: … of lead(II) chromate and lead(II) oxide. (PbCrO4 and PbO). Chrome orange can be made by precipitating ... toxic both from the contained lead and from the contained hexavalent chromium. …
Matched synonyms: … Chromic acid lead(2+) salt (1:2) ... Lead chromic acid oxide …

Matched symptoms: … , increased or decreased blood pressure, numbness around the face, and muscle weakness. High levels ... may result in changes in heart rhythm or paralysis and possibly death. Manganese mainly affects the ... nervous system and may cause behavioral changes and other nervous system effects, which include …
Matched description: … Barium permanganate is a chemical compound of barium and manganese. Barium is a metallic alkaline ... earth metal with the symbol Ba, and atomic number 56. It never occurs in nature in its pure form due ... to its reactivity with air, but combines with other chemicals such as sulfur or carbon and oxygen to …
Matched synonyms: … Barium permanganic acid ... Permanganic acid (hmno4), barium salt ... Permanganic acid, barium salt …

Matched description: … more complex and is not limited to blockade of the reduction of folic acid alone. Although rescue ... treatment with the olic acid antagonist aminopterin has been recognized since 1952 when aminopterin was ... a very unusual facies, skull anomalies, and skeletal defects.(OMIM). Aminopterin is an …
Matched synonyms: … 4-Aminofolic acid ... 4-Aminopteroylglutamic acid ... L-N-[p-[[(2,4-Diamino-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid …
Matched compound_type: … Folic Acid Antagonist …

Matched name: … 2-Buten-1-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)- …
Matched synonyms: … 2-Buten-1-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)- ... 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol …

Matched name: … 4-Penten-2-ol, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)- …
Matched synonyms: … 4-Penten-2-ol, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)- ... 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol …

Matched symptoms: … , aspiration pneumonia, pulmonary oedema and shock, as well as vomiting and bloody diarrhea. The CNS ... , cardiovascular and renal toxicity following acute iodine ingestion appear to be due to the corrosive ... gastroenteritis and resultant shock. Vomiting, hypotension and circulatory collapse may be noted …
Matched carcinogenicity: … is carcinogenic to humans (Group 1). (L2150) I-129 decays with low-energy beta and gamma emissions. …
Matched treatment: … not possible. Anaesthetics and antiemetics are administered to counter the symptoms of exposure, as …
Matched description: … Iodine is a chemical element that has the symbol I and atomic number 53. Chemically, iodine is the ... second least reactive of the halogens, and the second most electropositive halogen; trailing behind ... found in some minerals and soils. Iodine is an essential trace element for life, mainly as …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful health ... effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful ... health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …

Matched symptoms: … , headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3) …
Matched treatment: … substantial chronic exposure. Only preventing further exposure and treating the observed symptoms …
Matched description: … as commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause ... harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4) …